Activist 13D/13G Filings - EVENTIDE ASSET MANAGEMENT LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-14
12:49 pm
Purchase		13GMIRUM PHARMACEUTICALS INC
MIRM		EVENTIDE ASSET MANAGEMENT LLC2,693,581
5.78%		636,581increase
(+30.95%)		View
2024-02-14
12:43 pm
Sale		13GANNEXON INC
ANNX		EVENTIDE ASSET MANAGEMENT LLC0
0%		-3,626,508decrease
(Position Closed)		View
2024-02-14
12:36 pm
Sale		13GXOMETRY, INC. CLASS A
XMTR		EVENTIDE ASSET MANAGEMENT LLC5,727,770
12.62%		-2,569decrease
(-0.04%)		View
2024-02-14
12:29 pm
Sale		13GVECTIVBIO HLDG AG
VECT		EVENTIDE ASSET MANAGEMENT LLC0
0%		-3,405,644decrease
(Position Closed)		View
2024-02-14
12:21 pm
Unchanged		13GPRAXIS PRECISION MEDICINES INC
PRAX		EVENTIDE ASSET MANAGEMENT LLC0
0%		0
(Unchanged)		View
2024-02-14
12:18 pm
Purchase		13GMARINUS PHARMACEUTICALS INC
MRNS		EVENTIDE ASSET MANAGEMENT LLC4,529,997
8.3%		1,379,997increase
(+43.81%)		View
2024-02-14
12:15 pm
Unchanged		13GFREELINE THERAPEUTICS HLDGS
FRLN		EVENTIDE ASSET MANAGEMENT LLC0
0%		0
(Unchanged)		View
2024-02-14
12:04 pm
Purchase		13GCOLLEGIUM PHARMACEUTICAL INC C
COLL		EVENTIDE ASSET MANAGEMENT LLC2,630,478
8.07%		885increase
(+0.03%)		View
2024-02-14
12:02 pm
Sale		13G908 DEVICES INC
MASS		EVENTIDE ASSET MANAGEMENT LLC1,430,995
4.42%		-799,670decrease
(-35.85%)		View
2024-02-14
11:59 am
Purchase		13GKORRO BIO INC
KRRO		EVENTIDE ASSET MANAGEMENT LLC546,325
6.83%		546,325increase
(New Position)		View
2024-02-14
11:54 am
Purchase		13GINOZYME PHARMA INC
INZY		EVENTIDE ASSET MANAGEMENT LLC3,179,837
5.15%		3,179,837increase
(New Position)		View
2024-02-14
11:48 am
Purchase		13GCELLDEX THERAPEUTICS INC C
CLDX		EVENTIDE ASSET MANAGEMENT LLC3,630,013
6.64%		3,630,013increase
(New Position)		View
2023-12-11
5:15 pm
Purchase		13GZENTALIS PHARMACEUTICALS INC C
ZNTL		EVENTIDE ASSET MANAGEMENT LLC11,559,975
16.34%		3,745,936increase
(+47.94%)		View
2023-12-11
5:14 pm
Purchase		13GAURA BIOSCIENCES INC
AURA		EVENTIDE ASSET MANAGEMENT LLC5,802,682
11.82%		3,551,314increase
(+157.74%)		View
2023-12-11
5:13 pm
Purchase		13GLEXEO THERAPEUTICS INC
LXEO		EVENTIDE ASSET MANAGEMENT LLC3,002,831
11.93%		3,002,831increase
(New Position)		View
2023-11-13
4:10 pm
Purchase		13GVYNE THERAPEUTICS INC PAR$
VYNE		EVENTIDE ASSET MANAGEMENT LLC1,394,336
9.99%		1,394,336increase
(New Position)		View
2023-11-13
2:43 pm
Purchase		13GXOMETRY, INC. CLASS A
XMTR		EVENTIDE ASSET MANAGEMENT LLC5,730,339
12.65%		5,730,339increase
(New Position)		View
2023-10-10
3:40 pm
Purchase		13GZENTALIS PHARMACEUTICALS INC C
ZNTL		EVENTIDE ASSET MANAGEMENT LLC7,814,039
11.07%		7,814,039increase
(New Position)		View
2023-02-14
3:04 pm
Unchanged		13GVITAL FARMS INC
VITL		EVENTIDE ASSET MANAGEMENT LLC0
0%		0
(Unchanged)		View
2023-02-14
3:00 pm
Sale		13GSUTRO BIOPHARMA INC
STRO		EVENTIDE ASSET MANAGEMENT LLC0
0%		-2,708,975decrease
(Position Closed)		View
Goto 0, 1, 2, 3, Next